Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04379843 · ClinicalTrials.gov registry record
The Efficacy of Implementing a Treatment Algorithm in Managing Patent Ductus Arteriosus (PDA) in the Extremely Low Birth Weight Neonatal Population.
A clinical trial, sponsored by Pediatrix.
- Completed
- Registry status
- 208
- Enrollment target
NCT04379843 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 208 participants.
The verdict
NCT04379843 has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
Study Summary
To evaluate whether utilizing a standardized patent ductus arteriosus (PDA) treatment algorithm in managing ELBW (extremely low birth weight) neonates ≤1000 grams (g) improves clinical outcomes and helps prevent undesirable side effects from PDAs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2016-07-27 |
| Est. Completion | 2021-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04379843
The ClinicalTrials.gov registry entry for NCT04379843 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pediatrix, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04379843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04379843 about?
NCT04379843 is a clinical study titled "The Efficacy of Implementing a Treatment Algorithm in Managing Patent Ductus Arteriosus (PDA) in the Extremely Low Birth Weight Neonatal Population.". To evaluate whether utilizing a standardized patent ductus arteriosus (PDA) treatment algorithm in managing ELBW (extremely low birth weight) neonates ≤1000 grams (g) improves clinical outcomes and helps prevent undesirable side effects from PDAs.
What is the current status of trial NCT04379843?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2016-07-27. Estimated completion is 2021-07-31.
Who is sponsoring clinical trial NCT04379843?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.